Comparative effectiveness of risankizumab vs. ustekinumab in bio-naïve Crohn's disease patients: A real-world multicentre retrospective cohort study

被引：0
|
作者：
Aldiabat, M. [1 ]
Yarur, A. [2 ]
Peyrin-Biroulet, L. [3 ]
Loftus-Jr, E., V [4 ,5 ]
Colombel, J. F.
Deepak, P. [6 ]
机构：
[1] Washington Univ St Louis, Sch Med, Gastroenterol, St Louis, MO USA
[2] Cedars Sinai Med Ctr, Gastroenterol, Los Angeles, CA USA
[3] Nancy Univ Hosp, Inflammatory Bowel Dis IBD Unit, Vandoeuvre Les Nancy, France
[4] Mayo Clin, Coll Med, Gastroenterol, Rochester, MN USA
[5] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA
[6] Washington Univ, Sch Med St Louis, Gastroenterol, St Louis, MO USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0141
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP102
引用
收藏
页码：i268 / i269
页数：2
相关论文
共 50 条
  • [1] Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn's disease patients: a retrospective multicenter study
    Na, Ji Eun
    Park, Yong Eun
    Park, Jongha
    Kim, Tae-Oh
    Lee, Jong Hoon
    Park, Su Bum
    Kim, Soyoung
    Lee, Seung Bum
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [2] Effectiveness, Treatment Pattern, and Safety of Ustekinumab Among Bio-Naïve Patients With Crohn's Disease in Real-World Clinical Settings in China
    Yao, Lingya
    Lin, Xiaoqing
    Tang, Jian
    Gao, Han
    Gao, Xiang
    Cao, Qian
    Chen, Minhu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1012 - S1013
  • [3] Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study
    Rogério Serafim Parra
    Júlio Maria Fonseca Chebli
    Natália Sousa Freitas Queiroz
    Aderson Omar Mourão Cintra Damião
    Matheus Freitas Cardoso de Azevedo
    Liliana Andrade Chebli
    Erika Ruback Bertges
    Antonio José Tiburcio Alves Junior
    Orlando Ambrogini Junior
    Bianca Loyo Pona Schiavetti da Silva
    Marcio Lubini
    Mauro Bafutto
    Cristina Flores
    Eduardo Garcia Vilela
    Sandra Felice Boratto
    Newton Luiz Tricarico Gasparetti Junior
    Flavio Steinwurz
    Nayara Salgado Carvalho
    Omar Féres
    José Joaquim Ribeiro da Rocha
    BMC Gastroenterology, 22
  • [4] Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study
    Elford, A.
    Bishara, M.
    Plevris, N.
    Gros, B.
    Constantine-Cooke, N.
    Goodhand, J.
    Kennedy, N.
    Ahmad, T.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1523 - I1525
  • [5] Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study
    Elford, Alexander Thomas
    Bishara, Maria
    Plevris, Nikolas
    Gros, Beatriz
    Constantine-Cooke, Nathan
    Goodhand, James
    Kennedy, Nicholas A.
    Ahmad, Tariq
    Lees, Charlie W.
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (04) : 297 - 304
  • [6] REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN CROHN'S DISEASE; A UK MULTICENTRE RETROSPECTIVE COHORT STUDY
    Elford, Alexander T.
    Bishara, Maria
    Plevris, Nikolas
    Gros, Beatriz
    Constantine-Cooke, Nathan
    Goodhand, James
    Kennedy, Nicholas A.
    Ahmad, Tariq
    Lees, Charlie W.
    GASTROENTEROLOGY, 2024, 166 (05) : S1451 - S1452
  • [7] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Na<spacing diaeresis>ive Patients With Complex Crohn's Disease: Results From the EVOLVE Expansion Study
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Khan, Zaeem
    Bassel, Marielle
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Scharl, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S627 - S628
  • [8] Patients with Crohn's disease treated with ustekinumab vs. vedolizumab in real-world settings
    Chiorean, M.
    Jiang, J.
    Candela, N.
    Chen, G.
    Romdhani, H.
    Latremouille-Viau, D.
    Shi, S.
    Bungay, R.
    Fan, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S630 - S630
  • [9] Real-world effectiveness and safety of Risankizumab in Crohn's Disease
    Mcshane, C.
    Olivera Sendra, P. A.
    Kim, J.
    Milgrom, R.
    Stempak, J.
    Nguyen, G.
    Weizman, A., V
    Croitoru, K.
    Gallinger, Z.
    Huang, V
    Steinhart, H.
    Targownik, L.
    Lee, S. H.
    Silverberg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2023 - I2024
  • [10] Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
    Plevris, Nikolas
    Fulforth, James
    Siakavellas, Spyros
    Robertson, Andrew
    Hall, Rebecca
    Tyler, Amy
    Jenkinson, Philip W.
    Campbell, Iona
    Chuah, Cher Shiong
    Kane, Claire
    Veryan, Jennifer
    Lam, Wai Liam
    Saunders, Jayne
    Kelly, Christopher
    Gaya, Daniel
    Jafferbhoy, Hasnain
    Macdonald, Jonathan C.
    Seenan, John Paul
    Mowat, Craig
    Naismith, Graham
    Potts, Lindsay F.
    Sutherland, Diarmid Ian
    Watts, David
    Arnott, Ian
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2067 - 2075
12345